Actively Recruiting
Improving Diagnosis and Management of Constitutional Bone Marrow Failure Through a National Network Using Biological and Genetic Data
Led by Istituto Giannina Gaslini · Updated on 2026-10-16
250
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers aim to improve diagnosis and treatment of constitutional bone marrow failure syndromes CMF, which are rare genetic disorders with unclear causes and symptoms. The study focuses on patients who may be misdiagnosed with idiopathic acquired aplastic anemia AAA or bone marrow failure BMF, seeking to better understand and classify these conditions using clinical, family, and immunological data. Artificial intelligence tools will be used to enhance diagnostic accuracy. This observational study involves enrolling patients diagnosed with various genetic bone marrow failure disorders including Fanconi anemia, dyskeratosis congenita and other telomere biology disorders, congenital neutropenia, primary immune regulatory disorders, congenital amegakaryocytic thrombocytopenia, and acquired aplastic anemia, with or without paroxysmal nocturnal hemoglobinuria. Participants are grouped based on these specific diagnoses to define well-characterized cohorts. Participants provide biological and genetic samples that will be processed and analyzed according to the study protocol. Researchers will assess early diagnosis and molecular characteristics of CMF and AAA over a 24-month period. The study is led by Istituto Giannina Gaslini and involves collection of clinical, family history, and immunological information to identify biomarkers and develop disease-specific guidelines for improved patient care.
CONDITIONS
Brief Title
Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data
Research Team
C
Carlo Dufour
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here